Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
Chonmaitree T et al. |
Effect of viral respiratory tract infection on outcome of acute otitis media. |
1992 |
J. Pediatr. |
pmid:1534364
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
MacGowan AR et al. |
Synergy testing of macrolide combinations using the chequerboard technique. |
1993 |
J. Antimicrob. Chemother. |
pmid:8144439
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Walker LL et al. |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. |
1993 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8326182
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|